ZA802909B - Pyrimidine compounds, processes for their preparation, pharmaceutical preparations containing these compounds, and their use in therapeutics - Google Patents
Pyrimidine compounds, processes for their preparation, pharmaceutical preparations containing these compounds, and their use in therapeuticsInfo
- Publication number
- ZA802909B ZA802909B ZA00802909A ZA802909A ZA802909B ZA 802909 B ZA802909 B ZA 802909B ZA 00802909 A ZA00802909 A ZA 00802909A ZA 802909 A ZA802909 A ZA 802909A ZA 802909 B ZA802909 B ZA 802909B
- Authority
- ZA
- South Africa
- Prior art keywords
- compounds
- therapeutics
- processes
- preparation
- pharmaceutical preparations
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH466979 | 1979-05-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA802909B true ZA802909B (en) | 1981-05-27 |
Family
ID=4280399
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA00802909A ZA802909B (en) | 1979-05-18 | 1980-05-16 | Pyrimidine compounds, processes for their preparation, pharmaceutical preparations containing these compounds, and their use in therapeutics |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP0019811A1 (xx) |
| JP (1) | JPS55154971A (xx) |
| KR (1) | KR830002757A (xx) |
| AR (1) | AR228256A1 (xx) |
| AU (1) | AU5848480A (xx) |
| DD (1) | DD150609A5 (xx) |
| DK (1) | DK214480A (xx) |
| ES (1) | ES8104279A1 (xx) |
| FI (1) | FI801600A (xx) |
| GB (1) | GB2052487B (xx) |
| GR (1) | GR68453B (xx) |
| IE (1) | IE49803B1 (xx) |
| IL (1) | IL60086A (xx) |
| MA (1) | MA18829A1 (xx) |
| NO (1) | NO801469L (xx) |
| NZ (1) | NZ193730A (xx) |
| OA (1) | OA06533A (xx) |
| PL (1) | PL224313A1 (xx) |
| PT (1) | PT71251A (xx) |
| ZA (1) | ZA802909B (xx) |
| ZW (1) | ZW11880A1 (xx) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4507146A (en) * | 1982-12-28 | 1985-03-26 | Ciba-Geigy Corporation | 2,4-Diamino-6-halo-5-trifluoromethylpyrimidines having herbicidal activity |
| DE3829469A1 (de) * | 1988-08-31 | 1990-03-01 | Bayer Ag | Verfahren zur herstellung von substituierten n-azinyl-n'-sulfonyl-isothioharnstoffen und n-azinyl-iminodithiokohlensaeure-s,s-diester als zwischenprodukte zu ihrer herstellung |
| CA2269971A1 (en) * | 1997-09-03 | 1999-03-11 | Trent Lee Abraham | Pyrimidine derivatives |
| US7473691B2 (en) | 2000-09-15 | 2009-01-06 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
| JP4922539B2 (ja) | 2000-09-15 | 2012-04-25 | バーテックス ファーマシューティカルズ インコーポレイテッド | プロテインキナーゼインヒビターとして有用なピラゾール化合物 |
| US6660731B2 (en) | 2000-09-15 | 2003-12-09 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
| NZ526470A (en) | 2000-12-21 | 2006-03-31 | Vertex Pharma | Pyrazole compounds useful as protein kinase inhibitors |
| SK9562003A3 (en) * | 2001-01-31 | 2004-04-06 | Synaptic Pharma Corp | Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
| EP1483247B1 (en) | 2002-03-13 | 2009-06-24 | Euro-Celtique S.A. | Aryl substituted pyrimidines and the use thereof |
| WO2003078427A1 (en) | 2002-03-15 | 2003-09-25 | Vertex Pharmaceuticals, Inc. | Azolylaminoazines as inhibitors of protein kinases |
| JP2005520821A (ja) * | 2002-03-15 | 2005-07-14 | チバ スペシャルティ ケミカルズ ホールディング インコーポレーテッド | ４−アミノピリミジン及び表面の抗菌処理のためのその使用 |
| MY141867A (en) | 2002-06-20 | 2010-07-16 | Vertex Pharma | Substituted pyrimidines useful as protein kinase inhibitors |
| AU2003257078B2 (en) | 2002-08-02 | 2010-04-01 | Vertex Pharmaceuticals Incorporated | Pyrazole compositions useful as inhibitors of GSK-3 |
| WO2004072029A2 (en) | 2003-02-06 | 2004-08-26 | Vertex Pharmaceuticals Incorporated | Pyrazolopyridazines useful as inhibitors of protein kinases |
| WO2007022384A2 (en) | 2005-08-18 | 2007-02-22 | Vertex Pharmaceuticals Incorporated | Pyrazine kinase inhibitors |
| EP1951715B1 (en) | 2005-11-03 | 2013-09-04 | Vertex Pharmaceuticals Incorporated | Aminopyrimidines useful as kinase inhibitors |
| ATE457311T1 (de) | 2006-11-02 | 2010-02-15 | Vertex Pharma | Als inhibitoren von proteinkinasen geeignete aminopyridine und aminopyrimidine |
| EP2099787B1 (en) | 2006-12-19 | 2010-07-21 | Vertex Pharmaceuticals, Inc. | Aminopyrimidines useful as inhibitors of protein kinases |
| KR20090120510A (ko) | 2007-03-09 | 2009-11-24 | 버텍스 파마슈티칼스 인코포레이티드 | 단백질 키나제 억제제로서 유용한 아미노피리미딘 |
| CA2679701A1 (en) | 2007-03-09 | 2008-09-18 | Vertex Pharmaceuticals Incorporated | Aminopyridines useful as inhibitors of protein kinases |
| NZ579446A (en) | 2007-03-09 | 2012-02-24 | Vertex Pharma | Aminopyrimidines useful as inhibitors of protein kinases |
| AU2008240313A1 (en) | 2007-04-13 | 2008-10-23 | Aj Park | Aminopyrimidines useful as kinase inhibitors |
| CN101801959A (zh) | 2007-05-02 | 2010-08-11 | 沃泰克斯药物股份有限公司 | 可用作激酶抑制剂的氨基嘧啶类化合物 |
| EP2152694A2 (en) | 2007-05-02 | 2010-02-17 | Vertex Pharmaceuticals Incorporated | Thiazoles and pyrazoles useful as kinase inhibitors |
| AU2008282156B2 (en) | 2007-07-31 | 2014-07-17 | Vertex Pharmaceuticals Incorporated | Process for preparing 5-fluoro-1H-pyrazolo [3, 4-b] pyridin-3-amine and derivatives thereof |
| EP2323622A1 (en) | 2008-09-03 | 2011-05-25 | Vertex Pharmaceuticals Incorporated | Co-crystals and pharmaceutical formulations comprising the same |
| PL2364314T3 (pl) * | 2008-12-09 | 2014-08-29 | Gilead Sciences Inc | Modulatory receptorów Toll-podobnych |
| KR102328682B1 (ko) * | 2018-08-27 | 2021-11-18 | 주식회사 대웅제약 | 신규한 헤테로사이클릭아민 유도체 및 이를 포함하는 약학 조성물 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE754832A (fr) * | 1969-08-14 | 1971-02-15 | Beecham Group Ltd | Iminazolines |
-
1980
- 1980-05-05 MA MA19025A patent/MA18829A1/fr unknown
- 1980-05-13 DD DD80221082A patent/DD150609A5/de unknown
- 1980-05-14 ES ES491514A patent/ES8104279A1/es not_active Expired
- 1980-05-15 IL IL60086A patent/IL60086A/xx unknown
- 1980-05-15 NZ NZ193730A patent/NZ193730A/xx unknown
- 1980-05-16 GR GR61963A patent/GR68453B/el unknown
- 1980-05-16 ZA ZA00802909A patent/ZA802909B/xx unknown
- 1980-05-16 AU AU58484/80A patent/AU5848480A/en not_active Abandoned
- 1980-05-16 GB GB8016309A patent/GB2052487B/en not_active Expired
- 1980-05-16 IE IE1023/80A patent/IE49803B1/en unknown
- 1980-05-16 NO NO801469A patent/NO801469L/no unknown
- 1980-05-16 PT PT71251A patent/PT71251A/pt unknown
- 1980-05-16 FI FI801600A patent/FI801600A/fi not_active Application Discontinuation
- 1980-05-16 EP EP80102724A patent/EP0019811A1/de not_active Withdrawn
- 1980-05-16 ZW ZW118/80A patent/ZW11880A1/xx unknown
- 1980-05-16 DK DK214480A patent/DK214480A/da not_active Application Discontinuation
- 1980-05-17 OA OA57113A patent/OA06533A/xx unknown
- 1980-05-17 PL PL22431380A patent/PL224313A1/xx unknown
- 1980-05-17 JP JP6586380A patent/JPS55154971A/ja active Pending
- 1980-05-17 KR KR1019800001944A patent/KR830002757A/ko unknown
- 1980-05-19 AR AR281109A patent/AR228256A1/es active
Also Published As
| Publication number | Publication date |
|---|---|
| ES491514A0 (es) | 1981-04-16 |
| FI801600A (fi) | 1980-11-19 |
| DK214480A (da) | 1980-11-19 |
| OA06533A (fr) | 1981-07-31 |
| KR830002757A (ko) | 1983-05-30 |
| GB2052487B (en) | 1983-05-11 |
| NO801469L (no) | 1980-11-19 |
| DD150609A5 (de) | 1981-09-09 |
| PL224313A1 (xx) | 1981-02-13 |
| GB2052487A (en) | 1981-01-28 |
| IL60086A0 (en) | 1980-07-31 |
| ES8104279A1 (es) | 1981-04-16 |
| EP0019811A1 (de) | 1980-12-10 |
| JPS55154971A (en) | 1980-12-02 |
| IE801023L (en) | 1980-11-18 |
| AU5848480A (en) | 1980-11-20 |
| IL60086A (en) | 1984-03-30 |
| PT71251A (en) | 1980-06-01 |
| IE49803B1 (en) | 1985-12-25 |
| GR68453B (xx) | 1981-12-30 |
| ZW11880A1 (en) | 1980-12-17 |
| NZ193730A (en) | 1982-12-21 |
| AR228256A1 (es) | 1983-02-15 |
| MA18829A1 (fr) | 1980-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA802909B (en) | Pyrimidine compounds, processes for their preparation, pharmaceutical preparations containing these compounds, and their use in therapeutics | |
| DE3067252D1 (en) | Cyclopeptides and pharmaceutical preparations thereof, process for their preparation and their use | |
| MY8500051A (en) | Novel 1-aryl-2-acylamido-3-fluoro-1-propanols, theiri preparation and pharmaceutical composition containing them | |
| IL63913A0 (en) | Pyrimidone derivatives,process for their preparation,pharmaceutical compositions containing them and their use | |
| DE3062310D1 (en) | Pyrimidone derivatives, processes for their preparation and pharmaceutical compositions containing them | |
| PH16228A (en) | Triazolo pyridazine derivatives,pharmaceutical composition containing the same and their use | |
| DE3262536D1 (en) | N-dihydrothiazolyl-3-quinoleine carboxyamide derivatives, their salts, their preparation and use as pharmaceutical preparations, and pharmaceutical preparations containing them | |
| IL59665A0 (en) | Xanthine derivatives,process for their preparation and their use in pharmaceutical compositions | |
| GB2060633B (en) | Isocyanuric acid derivatives preparation and pharmaceutical use thereof | |
| IL59410A0 (en) | Pyrazole derivatives,pharmaceutical formulations containing these derivatives and processes for their preparation | |
| DE2966413D1 (en) | Pyrimidinone derivatives, processes for preparing them and pharmaceutical compositions containing them | |
| GB2053196B (en) | Derivatives of 5h-furanone-2 and of 3h-dihydrofuranone-2,the process for preparing the same and their application in therapeutics | |
| DE3062268D1 (en) | Alkoxybenzylpyridopyrimidines, methods for their preparation and pharmaceutical formulations thereof | |
| IL60325A0 (en) | Novel quinazoline derivatives and pharmaceutical preparations containing them | |
| IL61240A0 (en) | Quinazoline derivatives, their preparation and pharmaceutical compositions containing them | |
| ZA793131B (en) | Indolealkylamines,pharmaceutical formulations containing these,and processes for their preparation | |
| ZA812034B (en) | Phrimidyl-quinazolines,process for their preparation pharmaceutical formulations containing these compounds,and their use | |
| CY1263A (en) | Glucofuranos-6-yl-nitroso urea derivatives,processes for their preparation and their use in pharmaceutical compositions | |
| IL59664A0 (en) | Xanthine derivatives,process for their preparation and their use in pharmaceutical compositions | |
| DE3168978D1 (en) | Thiazoline derivatives, their preparation and use and pharmaceutical preparations containing them | |
| DE2862102D1 (en) | Pyrimido (4,5-c) pyridazines, their use in pharmaceutical preparations, and process for their preparation | |
| ZA793336B (en) | Novel phenylpiperidine derivatives,processes for their preparation,pharmaceutical preparations containing these derivatives and their use | |
| DE3062972D1 (en) | Pyridazopyridazine derivatives, processes for their preparation and pharmaceutical compositions containing these pyridazopyridazine derivatives | |
| ZW15180A1 (en) | Aminothiadiazolyl compounds processes for the manufacture thereof and pharmaceutical preparations containing such compounds and the use thereof | |
| EP0018077A3 (en) | Phenylmorphans, processes for their preparation, pharmaceutical compositions containing them, and 4-phenyl-tetrahydro-pyridines |